medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2005, Number 6

<< Back Next >>

Rev Mex Urol 2005; 65 (6)

Human papilloma virus in male. Sharing responsibility

Guzmán EJ, Baltasar RLM, Molina J

Language: Spanish
References: 39
Page: 431-438
PDF size: 134.27 Kb.


ABSTRACT

The human papillomavirus (HPV) is an infection with high prevail world wide (in the whole world), especially young women with sexual activity. Many sectional cross and prevalence studies have been accomplished to determine the risk factor that causes the infection. Some of these risks are women with several sexual couples, kind of viral cepa and age. It is considered that high risk virus or oncogenic may cause almost all the uterine cervix cancer (CaCu) and premalignant intra-epithelial injury. The relevance of this infection stay on the impact of the health system and in the high rate of morbid-mortality caused by CaCu Mexico haven’t succeeded in decreasing the deaths by CaCu so far How responsible is the man that has a couple with CaCu and pre-malignant injury?


REFERENCES

  1. Fields HM. Virology: B.N. Fields Ed. Papillomavirinae: The Virus and their Replication. Third edition. Philadelphia; 1996, pp. 2045-76.

  2. Mas AG. Infección por papilomavirus. Tema monográfico LXI Congreso Nacional de Urología. Asociación Española de Urología. Ed. Lab. Knoll, Mayo, 1996.

  3. Richart RM, et al. Human Papillomavirus IAC Task Force Summary. Acta Cytológica 1998; 42: 50-8.

  4. Broker TR. Structure and genetic expression of papillomaviruses. Obstet Gynecol North Am 1987; 14: 329.

  5. Pfister H. General introduction to papillomaviruses, properties of the virions, and classification. In: Papillomaviruses and Human Cancer. Boca Raton, Florida: CRC Press; 1990.

  6. Marrazzo JM, Koutsky LA, Stine KL, et al. Genital human papillomavirus infection in women who have sex with woman. J Infect Dis 1998; 178: 1604-9.

  7. Muñoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 248: 518-27.

  8. Stoller MH. A brief synopsis of the role of human papillomavirus in cervical carcinogenesis. Am J Obstet Gynecol 1996; 175(part 2, num. 4): 1091-8.

  9. Shiffman M, Phillip E. Human papillomavirus epidemiology and public health. Arch Pathol Lab Med 2003; 127(8): 930.

  10. 10.Solomon DE, Shiffman M, Tarone R, for the ATLS group. Comparison of three management strategies for patients with atypical squamosus cell of undetermined significance. J Natl Cancer Inst (Bethesda) 2001; 93: 293-9.

  11. 11.Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.

  12. 12.Ferlay J, Bray F, Parkin MD. GLOBOCAN 2000: Cancer Incidence, Mortality and prevalence Worldwide, Version 1.0. Lyon: IARC Cancer Base No 5; 2001.

  13. 13.International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the evaluation of the carcinogenic Risks to Human. Vol. 64 Human Papillomaviruses. Lyon, France: World Health Organization; 1995.

  14. 14.Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: A Worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.

  15. 15.Giuliano AR, Papenfus M, Abrahamsen M, Inserra P. Differences in factors associated with oncogenic and mononcogenic human papillomavirus infection at the United States-Mexico Border.

  16. 16.Gloria YF, Bierman R, Beardsley NP, et al. Natural history of cervicovaginal papillomavirus infection in young women. 1998; 338: 423-8.

  17. 17.Escandón RC, Escobedo PJ, Martínez MOG. Epidemiología del cáncer del cuello uterino en el Instituto Mexicano del Seguro Social. Alonso/Lazcano/Hernández. Cáncer cervicouterino, diagnóstico, prevención y control. 1ª Ed. México: Ed. Panamericana; 2001, pp. 121-31.

  18. 18.Torroella-Kuori M, et al. HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 1998; 70(1): 115-20.

  19. 19.Palefsky JM, Barraso R. Infección y enfermedad por el virus del papiloma humano en varones. Clin Gin Obstet (Temas actuales, virus del papiloma humano) 1996; 4(11): 825-964.

  20. 20.Schiffman MH, Vauer HM, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasm. J Nath Cancer Inst 1993; 85: 958-64.

  21. 21.Lorinez AT. Métodos moleculares para la detección de infección por el virus del papiloma humano. Temas actuales. Virus del papiloma humano. Parte 1, Vol. 3. México: Mc Graw-Hill Interamer; 1996, pp. 647-69.

  22. 22.Hellsen WT. Laser treatment of squamous cell carcinoma of the penis. J Urol 1995; 1020-3.

  23. 23.Barrasso R, et al. High prevalence of papillomavirus associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987; 317: 916-23.

  24. 24.Diller J, Von Krogh G, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl 2000; 205: 189-93.

  25. 25.Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998; 159: 86-90.

  26. 26.Zazove P, Carothers BS, Redd BD. Genital human papillomavirus infection. Am Fam Phys 1991; 43(4): 1279-89.

  27. 27.Strand A, Rylander E, Zenbel I, Kraz W. Histopathological examination of penile intraepithelial lesion is of limited diagnostic value in human papillomavirus infection. Sex Transm Dis 1996; 23(4): 293-8.

  28. 28.Carrillo A, Mohar A, Meneses A, Frías-Mendivil M, Solorza G, Lizano M. Utilidad en la combinación de oligonucleótidos universales para detección de virus de papiloma humano en cáncer cervicouterino y lesiones premalignas. Salud Pública Méx 2004; 46: 7-15.

  29. Farenczy A. Epidemiology and clinical pathophysiology of Condylomata acuminata. Am J Obstet Gynecol 1995; 172: 1331-9.

  30. Leyva-López AG, Aranda-Flores CE, Conde-González C, Lazcano-Ponce EC. Low yield on HPV DNA determination in the distal region of the male urethra. Salud Pública Méx 2003; 45(Supp 5): 589-93.

  31. Calleja-Macías IE, Kalantari M, Huh, et al. Genomic diversity of human papillomavirus-16, 18, 31 and 35 isolates in a Mexican population and relationship to European, African and Native American Variants. Virology 2004; 319(2): 315-23.

  32. Lai YM, Lee JF, Huang HY, Soong YK, Yang FP, Pao CC. The effect of human papillomavirus infection on sperm cell motility. Fertil Steril 1997; 67(6): 1152-5.

  33. Lai YM, Yang FP, Pao CC. Human papillomavirus deoxyribonucleic acid and ribonucleic acid in seminal plasma and sperm cells. Fertil Steril 1996; 65(5): 1026-30.

  34. Chan PJ, Su BC, Kalugdan T, Serg IM, Tredway DR, King A. Human papillomavirus gene sequences in washed human sperm deoxyribonucleic acid. Fertil Steril 1994; 61(5): 982-5.

  35. Weiss JP, November S, Curtin CHT. Recurrent penile Condylomata acuminata in a 17-month-old boy. J Urol 1986; 136: 468-71.

  36. Castellsague X, Bosch FX, Muñoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2003; 346: 1105-12.

  37. Schiffman M, Castle PE. Human papillomavirus: Epidemiology and Public Health. Arch Pathol Lab Med 2003; 127(8): 930-4.

  38. Kahn JA, Bernstein DI. Human papillomavirus vaccines (Concise reviews of Pediatric Infectious Diseases). Pediatr Infect Dis J 2003; 22(5): 443-5.

  39. Harro CD, et al. Safety and immunogenicity trial of HPV VLP vaccine. N Natl Cancer Inst 2001; 93: 284-92.




2020     |     www.medigraphic.com